Covid-19 Vaccine
-
Haffkine Bio-Pharma targets 22.8 crore Covaxin vials a year
The Mumbai-based company said that it will take least at one year time for the company to start actual production…
Read More » -
COVID-19 vaccinations may protect breast-fed babies: Study
The research provides that breastfeeding confers a long-lasting immune response in the nursing infants and toddlers of vaccinated mothers Nursing…
Read More » -
Prioritising who gets COVID-19 vaccine first saves lives: Study
The researchers modelled COVID-19 transmission rates and the optimal allocation of an initially limited vaccine supply in the US under…
Read More » -
RDIF, Panacea Biotec to produce 100 million doses of Sputnik V vaccine in India per year
The efficacy of Sputnik V is 91.6 per cent as confirmed by the data published in the leading medical journal, Lancet…
Read More » -
FDA authorises two changes to Moderna’s vaccine
According to a statement issued by Moderna, it plans to begin shipping the new 15-dose vials in the coming weeks…
Read More » -
Centre directs states, UTs to discontinue registrations of healthcare, frontline workers
Various inputs suggest that some ineligible beneficiaries are being registered as HCWs and FLWs and are getting vaccinated in complete…
Read More » -
Serum Institute delays expected launch of Novavax vaccine in India
Poonawalla recently said that the trials of Corovax had kicked off in India but did not say why the vaccine…
Read More » -
AstraZeneca’s US trial data a confidence booster for COVID-19 shot
The drugmaker said that interim data from trials in Chile, Peru and the US have found the vaccine was 79…
Read More » -
WHO approves Johnson & Johnson’s COVID-19 vaccine for emergency listing
This is the third COVID-19 vaccine after the two-shot regimens of Pfizer/BioNTech and AstraZeneca to receive backing from the WHO…
Read More » -
India studies post-vaccination adverse events of Covishield
India has reported 234 adverse events following immunisation (AEFIs), including 71 deaths, for both the vaccines till now Amid concerns…
Read More »
